SCHEMBL8938245

SCHEMBL8938245

CS(=O)(=O)Nc1ccc(CCN2CCCCC2OC(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.46
HRH3 Q9Y5N1 4/20 0.46
CYP2D6 P10635 2/20 0.42
OPRK1 P41145 2/20 0.42
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41
TSHR P16473 1/20 0.41
PMP22 Q01453 1/20 0.41
KMT2A Q03164 1/20 0.41
SLC6A2 P23975 1/20 0.41
CCR5 P51681 1/20 0.41
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8938519 0.91 KCNH2 (0.45) KCNH2HRH3CYP2D6LMNAMEN1
SCHEMBL8938404 0.90 KCNH2 (0.43) KCNH2HRH3CYP2D6LMNAMEN1
SCHEMBL8938332 0.89 SLC2A1 (0.43) KCNH2HRH3CYP2D6OPRM1LMNA
SCHEMBL8938356 0.84 CCR5 (0.46) KCNH2HRH3LMNAMEN1KMT2A
SCHEMBL8938317 0.82 HRH3 (0.40) KCNH2HRH3CYP2D6OPRM1SLC6A2
SCHEMBL8938187 0.81 CCR5 (0.47) HRH3CCR5ALDH1A1SMN1; SMN2
SCHEMBL8938361 0.81 GBA1 (0.41) KCNH2HRH3CYP2D6OPRM1SLC6A2
SCHEMBL8938514 0.81 HRH3 (0.42) HRH3
SCHEMBL8938621 0.81 SIGMAR1 (0.41) KCNH2HRH3CYP2D6OPRM1SLC6A2
SCHEMBL8938226 0.81 HRH3 (0.40) KCNH2HRH3CYP2D6OPRM1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5534626-A SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST INTERMEDIATES PFIZER INC. (US) 1996-07-09 US disclosed
US-5410046-A Selective muscarinic receptor antagonists PFIZER INC. (US) 1995-04-25 US disclosed
EP-0350309-B1 PIPERIDINE DERIVATIVES Pfizer Limited (GB) 1992-11-11 EP disclosed
US-5089505-A Anticholinergic agents PFIZER INC. (US) 1992-02-18 US disclosed
EP-0350309-A1 Piperidine derivatives Pfizer Limited (GB) 1990-01-10 EP disclosed